IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
May 7, 2026 - 20:22
IN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The company is advancing its next-generation gamma-delta T cell engager platform and expects to release initial animal data later this year.
In its glioblastoma program, IN8bio reported data showing a roughly 97 percent improvement in progression-free survival compared to standard-of-care treatment. The company plans to present updated median overall survival data at the ASCO 2026 conference.
IN8bio will host an R&D Day on May 21, 2026 in New York City to discuss its pipeline and future directions. The company continues to develop innovative gamma-delta T cell therapies designed to target and destroy cancer cells while potentially reducing side effects associated with traditional treatments.
Financial details from the first quarter were not disclosed in the summary, but the company remains focused on advancing its clinical programs and platform technology. IN8bio is headquartered in New York and trades on the Nasdaq under the ticker INAB.
MORE NEWS
September 20, 2026 - 09:51
Nvidia Stock And 2 US AI Infrastructure Plays Tied To Federal Defense SpendingWashington is turning its attention back to artificial intelligence and defense infrastructure. New proposals for an `AI Force` and a dedicated AI tsar point to growing federal interest in chips,...
September 19, 2026 - 19:53
Infosys (INFY) Lands a Brake Maker as Growth Stays in Low GearInfosys announced on August 18 a long-term agreement to handle the enterprise software operations for Knorr-Bremse AG, a German manufacturer of braking systems used in rail and commercial vehicles....
September 19, 2026 - 00:42
Greenfield Finance Director Expects Cash Reconciliation to Finish by DecemberGreenfield officials say the city`s cash reconciliation process is on track to wrap up by December, a timeline that would clear the way for a bond sale in January. The finance director told the...
September 18, 2026 - 12:18
Japan Rate Hike Puts Sumitomo Mitsui Financial Group Stock In FocusJapan has raised interest rates to a 31 year high, a decision that changes how money moves through the country`s economy. For years, near zero rates pushed investors toward riskier assets and...